The increase of the rate of hemopoietic recovery and clinical benefice of erytropoetin and granulocyte colony-stimulating factor with peripheral blood progenitor cells after intensive cyclic chemotherapy in high-risk breast cancer patients

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F60162694%3A_____%2F99%3A00000208" target="_blank" >RIV/60162694:_____/99:00000208 - isvavai.cz</a>
Result on the web
—
DOI - Digital Object Identifier
—

Result language
angličtina
Original language name
The increase of the rate of hemopoietic recovery and clinical benefice of erytropoetin and granulocyte colony-stimulating factor with peripheral blood progenitor cells after intensive cyclic chemotherapy in high-risk breast cancer patients
Original language description
The increase of the rate of hemopoietic recovery and clinical benefice of erytropoetin and granulocyte colony-stimulating factor with peripheral blood progenitor cells after intensive cyclic chemotherapy in high-risk breast cancer patients
Czech name
—
Czech description
—

Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FD - Oncology and haematology
OECD FORD branch
—

Project
<a href="/en/project/MO66020398129" target="_blank" >MO66020398129: Radiosenzitivity of hematopoietic progenitors (CD34+/AC133+) and effect of citokines on expansion ex vivo.</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Publication year
1999
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Result description